Table of Content

Open Access iconOpen Access

ARTICLE

Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7

Stéphanie Beq1, Florence Bugault1, Jean-Hervé Colle1, Olivier Lambotte2, Jean-François Delfraissy2, Jacques Thèze1

1 Unité d’Immunogénétique Cellulaire, Département de Médecine Moléculaire, Institut Pasteur, 25 rue du Dr Roux, 75724 Paris Cedex 15, France
2 Service de Médecine Interne, Assistance Publique–Hôpitaux de Paris, Centre Bicêtre, France

* Corresponding Author: J. Thèze, email

European Cytokine Network 2005, 16(4), 293-299.

Abstract

IL-7 is a crucial cytokine regulating lymphopoiesis and peripheral T lymphocyte homeostasis. Plasma IL-7 levels increase during HIV infection and, although antiretroviral therapy (ARV therapy) decreases these levels, they fail to return to normal. Immune reconstitution in most ARV-treated patients is only partial. We tested the possibility that the IL-7R system might be affected by ARV drugs. The effects of the antireverse transcriptase AZT and the anti-protease saquinavir on CD3- and CD3+CD28-induced T lymphocyte stimulation, in the presence (or absence) of IL-7, were studied in vitro. Small amounts of the drugs did not interfere with the capacity of IL-7 to stimulate T cell proliferation, but higher concentrations significantly decreased IL-7-induced T cell proliferation both in cells from HIV-infected patients and in cells from healthy donors. IL-7 is known to down-modulate its own receptor on the surface of CD4 and CD8 T lymphocytes in vitro. In CD4 lymphocytes from healthy donors or HIV-infected patients, neither AZT, nor saquinavir, nor a combination of the two, interfered with this property. In contrast, AZT + saquinavir worsened the IL-7-induced down-regulation of CD127 expression by CD8 T cells from HIV-infected patients, while no such effect was observed with CD8 T cells from healthy donors. Our data suggest that, under certain conditions, antiretroviral therapy could interfere with the expression and function of the IL-7/IL-7R system, and more particularly it may affect the CD8-lymphocyte compartment of HIV-infected patients.

Keywords

HIV, IL-7 receptor, CD127, AZT, saquinavir, immune restoration

Cite This Article

APA Style
Beq, S., Bugault, F., Colle, J., Lambotte, O., Delfraissy, J. et al. (2005). Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7. European Cytokine Network, 16(4), 293–299.
Vancouver Style
Beq S, Bugault F, Colle J, Lambotte O, Delfraissy J, Thèze J. Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7. Eur Cytokine Network. 2005;16(4):293–299.
IEEE Style
S. Beq, F. Bugault, J. Colle, O. Lambotte, J. Delfraissy, and J. Thèze, “Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7,” Eur. Cytokine Network, vol. 16, no. 4, pp. 293–299, 2005.



cc Copyright © 2005 The Author(s). Published by Tech Science Press.
This work is licensed under a Creative Commons Attribution 4.0 International License , which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
  • 35

    View

  • 34

    Download

  • 0

    Like

Share Link